Boholamide A, an APD-Class, Hypoxia-Selective Cyclodepsipeptide

Area of Science:

• Biochemistry
• Pharmacology
• Oncology

Background:

• Calcium homeostasis plays a role in cancer development.
• Targeting calcium pathways presents a potential strategy for novel cancer therapeutics.

Purpose of the Study:

• To identify novel compounds with anticancer activity by screening bacterial extracts.
• To investigate the mechanism of action and selectivity of identified compounds.

Main Methods:

• Assay development using a glioblastoma cell line.
• Screening of 1000 unique bacterial extracts.
• Isolation and identification of the active compound, boholamide A.
• Assessment of calcium ion (Ca2+) influx in glioblastoma and neuronal cells.
• Evaluation of hypoxia selectivity and mitochondrial targeting.

Main Results:

• Boholamide A (1), a 4-amido-2,4-pentadieneoate (APD)-class peptide, was identified.
• Boholamide A induces rapid Ca2+ influx in glioblastoma and neuronal cells at nanomolar concentrations.
• Boholamide A exhibits hypoxia selectivity, consistent with other APD-class compounds.
• The compound primarily targets mitochondria.

Conclusions:

• Boholamide A represents a novel APD scaffold with potential for anticancer drug development.
• Its hypoxia-selective cytotoxicity and calcium-modulating properties make it a promising candidate for glioblastoma and other cancers.
• Further research into APD-class compounds could yield new chemotherapeutic agents.